Universitätsklinikum Hamburg-eppendorf
Clinical trials sponsored by Universitätsklinikum Hamburg-eppendorf, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Brain Attack's hidden toll: new study probes Body's autonomic chaos Results expected Sep 2026 (estimated)
- 1,000 patients to reveal hidden dangers of kidney injury Results expected Sep 2026 (estimated)
- Skin tightening danger? top docs create safety rules for popular procedure Results expected Sep 2026 (estimated)
- New trial: will 24/7 vital sign monitoring save Post-Surgery patients? Results expected Nov 2026 (estimated)
- New hope for kids with brain cancer: less radiation may work just as well Results expected Dec 2026 (estimated)
-
Which heart valve design wins for small aortic openings?
Disease control Not yet recruitingThis trial compares two types of replacement heart valves used in a procedure called TAVI for people with severe aortic valve stenosis and a small aortic annulus. The two valves are the Meril Octapro+ and the Abbott Navitor. Researchers want to see which design provides better sa…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Heart attack without blockage: trial tests gentler blood thinners for SCAD
Disease control Not yet recruitingThis trial tests whether a less intensive antiplatelet therapy is safer and as effective as standard dual therapy for people with spontaneous coronary artery dissection (SCAD), a rare cause of heart attack in women aged 30–55. Unlike typical heart attacks, SCAD involves a tear in…
Phase 4 • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New 5-Drug cocktail aims to tackle High-Risk myeloma
Disease control Not yet recruitingThis study tests a new five-drug combination for people newly diagnosed with a high-risk form of multiple myeloma. The drugs include etentamig, isatuximab, bortezomib, lenalidomide, and dexamethasone. The trial will enroll 220 participants and first check safety, then see if the …
Phase 1/2 • Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
A simple care plan may shield older brains after surgery
Prevention Not yet recruitingThis study evaluates a multicomponent care program designed to prevent postoperative delirium in adults aged 65 and older undergoing surgery. The program includes preoperative screening for risk factors like frailty and cognitive impairment, patient and family education, and indi…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Can brain scans unlock the mystery of unexplained facial pain?
Knowledge-focused Not yet recruitingThis study investigates persistent idiopathic facial pain (PIFP), a chronic condition where people feel facial pain without any obvious nerve damage or dental cause. Researchers will compare 60 participants, including people with PIFP and healthy volunteers, using sensory tests a…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Aug 29, 2026 00:00 UTC
-
Blood clot marker may predict immunotherapy success in advanced skin cancer
Knowledge-focused Not yet recruitingThis study looks at whether a routine blood test measuring D-dimer levels can predict if the immunotherapy drug cemiplimab will control advanced cutaneous squamous cell carcinoma. Researchers will follow 116 patients starting cemiplimab in regular care, comparing disease control …
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC
-
Can a sugar pill make you happier? scientists study expectation effects on emotions
Knowledge-focused Not yet recruitingThis study looks at how positive expectations—like thinking you received a helpful treatment—can change how your brain processes emotions. Healthy adults will receive a saline nasal spray labeled as either oxytocin or saline on different days. Researchers will measure mood, brain…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Skin tightening danger? top docs create safety rules for popular procedure
Knowledge-focused Not yet recruitingThis study gathers 30 skin experts to agree on the safest ways to perform radiofrequency microneedling, a popular cosmetic treatment for tightening skin. They will create guidelines on who should get the treatment, how to do it safely, and how to avoid complications. No patients …
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC